Core Viewpoint - The biomanufacturing industry is emerging as a new engine for economic growth, with a significant focus on the new protein sector as a key area for development [1][2]. Group 1: New Protein Manufacturing Center - The National Investment Group and Wuxi City have established the National Investment New Protein Biomanufacturing Innovation Center to address bottlenecks in new protein research and industrialization [2][4]. - The center aims to accelerate the development and cost optimization of various new protein products, covering fields such as food, nutrition, healthcare, and materials [2][4]. Group 2: Challenges and Opportunities - New protein is defined as edible protein not reliant on traditional livestock or fishery methods, utilizing innovative technologies like microbial fermentation and synthetic biology [4]. - China faces a significant protein gap, with 2024 grain imports projected to exceed 158 million tons, including 105 million tons of soybeans, which are primarily used for animal feed [5]. - The shortage of edible protein has become a safety issue, prompting the government to promote comprehensive food resource development [5]. Group 3: Investment and Development Strategy - Since 2020, the new protein industry in China has shown strong growth, although the capital market's downturn in 2023 has posed challenges [5][6]. - The National Investment Group has established the National Investment Biomanufacturing Innovation Research Institute with a registered capital of 6 billion yuan, marking a significant step in supporting the biomanufacturing industry [5][6]. - The group aims to achieve a total output value of 60 billion yuan in the biomanufacturing sector by the end of the 14th Five-Year Plan [6]. Group 4: Financial Support and Collaboration - The National Investment Group manages funds exceeding 270 billion yuan, having invested over 4 billion yuan in 25 biomanufacturing companies [6][7]. - The group has partnered with various local governments to establish industry guidance funds, including a 2 billion yuan biomanufacturing venture capital fund in Tianjin [6][7]. - Future plans include collaborating with private capital to explore differentiated management of mixed-ownership enterprises, enhancing the vitality and competitiveness of the industry [7].

第十届生物基大会暨展览 Bio-based 2025 将于 5月25-27日·上海佘山茂御臻品之选酒店 举办， 由 4 位院士领衔100+企业高层和 顶尖专家 ，为生物基行业的下一个拾年"把脉问诊"。活动以" 行 业大会、创新展览、新叶奖评选与颁奖 " 三大板块同期进行，共设置 1场评选、6大论坛、17大专 场、4大特色对接&交流会 ，预 计将 超过 15 00+ 行业同仁出席。 向绿而行，向新而质 。第十届生物基大会立足 全球视野 和 下游用户需求 ，加速科技创新与产业创 新融合发展，助力行业上下游企业迈向新征程。 组织机构与展会信息 Bio-based 2025 01 大会主席团 主办单位 浙江省 生物基高分子材料重点实验室 宁波德泰中研信息科技有限公司（DT新材料） 协办单位 吉林省国科创新孵化投资有限公司 长春市新材料 产业知识产权运营服务中心 舟山市投资促进中心 支持单位 中国合成树脂协会生物基与可降解分会 中国合成橡胶工业协会热塑性弹性体分会 生物基材料产业技术创新战略联盟 生物质产业碳中和技术创新联盟 nova institute 韩国生物塑料协会（KBPA） 大会专家顾问团 （顾问专家无先后排 ...

清华大学刘德华教授 担任 第十届生物基大会暨展览 大会 顾问专家 ，并担任生物基评选 —— 2025（第三届）新叶奖NEW LEAF AWARD 2025 评审专家 。同时，刘德华教授多 次受邀出席由DT新材料主办的生物基、非粮生物质高值化利用、生物制造等产业交流大会。 【SynBioCon】 获 悉， 渥太华当地时间2025年5月15日，加拿大工程院（The Canadian Academy of Engineering）公布2025年 院士增选结果，此次共增选50名新院士和7名外籍院士。 清华大学化学工程系刘德华教授 成功当选7名外籍院士之一。 DT新材料专家库资料显示 ：刘德华教授主要研究领域为 生物质综合利用的生物炼制技术 。主持完成国家"863"重点项目—— 1,3-丙 二醇的生物炼制，新建或改建成万吨级生产装置三套，填补国内空白 ；主持研发酶法生物柴油技术及其产业化， 建成全球首套酶法生 物柴油工业化装置 ， 并已分别在巴西、马来西亚实现工业化示范 。已申请130余项发明专利，并有多项核心专利已获美国、欧盟、加 拿大、澳大利亚、日本、俄罗斯、新加坡、巴西、印度等二十多国授权，发表SCI收录论文20 ...

Core Viewpoint - The article highlights the launch of a specialized production line for high-end bioactive molecules by KaiXing Bio, marking a significant advancement in the synthetic biology industry in China [1][3]. Group 1: Company Overview - KaiXing Bio, established in May 2024, is a subsidiary of Beijing Green Kangcheng Biotechnology Co., Ltd., stemming from decades of research by Tsinghua University in the biotechnology field [1]. - The company focuses on next-generation biotechnology to create an intelligent manufacturing platform for the green production of high-end chemicals, providing sustainable bioactive raw material solutions for the global market [3]. Group 2: Production and Products - The newly launched factory in Changzhou will mass-produce high-value amino acids and bioactive raw materials, including N-acetylneuraminic acid, L-histidine, carnosine, decarboxylated carnosine, ergothioneine, rhodiola rosea glycosides, and ectoine, which are widely used in dietary supplements, functional skincare, and biomedicine [4]. - KaiXing Bio released the first batch of synthetic biological product standards in Jiangsu Province during the launch ceremony, setting a new quality benchmark for Chinese raw materials [5]. Group 3: Industry Impact and Future Plans - The combination of "raw materials + standards" aims to enhance the domestic substitution and standard system construction in the synthetic biology field, injecting strong momentum into the industry [7]. - The company plans to strengthen industry chain cooperation, promote green and sustainable biomanufacturing technology innovation, and continuously provide high-quality, environmentally friendly, and efficient bioactive raw material solutions to global customers [7]. - KaiXing Bio aims to expand its product matrix and accelerate its global market layout, promoting the concepts of health, beauty, and sustainability, while leading the active raw material industry with "Made in China" initiatives [7].

第十届生物基大会暨展览 Bio-based 2025 将于 5月25-27日·上海佘山茂御臻品之选酒店 举办， 由 4 位院士领衔100+企业高层和 顶尖专家 ，为生物基行业的下一个拾年"把脉问诊"。活动以" 行 业大会、创新展览、新叶奖评选与颁奖 " 三大板块同期进行，共设置 1场评选、5大论坛、17大专 场、4大特色对接&交流会 ，预 计将 超过 15 00+ 行业同仁出席。 向绿而行，向新而质 。第十届生物基大会立足 全球视野 和 下游用户需求 ，加速科技创新与产业创 新融合发展，助力行业上下游企业迈向新征程。 组织机构与展会信息 Bio-based 2025 01 大会主席团 主办单位 浙江省 生物基高分子材料重点实验室 宁波德泰中研信息科技有限公司（DT新材料） 协办单位 吉林省国科创新孵化投资有限公司 长春市新材料 产业知识产权运营服务中心 舟山市投资促进中心 支持单位 中国合成树脂协会生物基与可降解分会 中国合成橡胶工业协会热塑性弹性体分会 生物基材料产业技术创新战略联盟 生物质产业碳中和技术创新联盟 nova institute （顾问专家无先后排列顺序） 姚献平 Yao Xianping 杭 ...

Core Viewpoint - The collaboration between Wanhua Chemical and the Biological Island Laboratory aims to drive innovation in biomanufacturing and biobased materials, positioning the companies as leaders in the industry [1][3]. Group 1: Partnership and Support - On May 6, Wanhua Chemical and the Biological Island Laboratory officially signed a partnership agreement focusing on biobased materials and other innovative fields [1]. - The collaboration was initially announced on April 16, with support from the Guangzhou Science and Technology Bureau, which pledged to provide necessary policy and resource services [3]. Group 2: Wanhua Chemical's Strategic Focus - Since 2017, Wanhua Chemical has been investing in synthetic biology, establishing a comprehensive platform that includes upstream gene engineering, enzyme engineering, fermentation engineering, and downstream separation and purification [4]. - The company is primarily focused on three areas: nutrition and health, daily chemical care, and fragrance and flavor, enhancing its portfolio of high-end fine chemicals [5]. Group 3: Innovations in Biobased Products - Wanhua Chemical has made significant advancements in biobased materials, having developed the world's first 100% biobased TPU material in 2022, along with other products such as biobased TPU, polylactic acid (PLA), biobased polyether products, biobased emulsions, and biodegradable films [6]. - On February 19, the company launched the world's first biobased 1,3-butanediol, which is applicable in moisturizers and solvents for products like serums, cleansers, and sunscreens [7]. Group 4: Future Directions and Industry Engagement - In its latest 2024 annual report, Wanhua Chemical highlighted its commitment to exploring cutting-edge fields such as synthetic biology to prepare for future industry developments [10]. - The company will participate in the 10th Biobased Conference and Exhibition in Shanghai from May 25-27, where it will showcase its high-performance biobased nylon elastomers and discuss product strategies [11].

今天，利用生物经济50人论坛的活动，与大家分享一下对生物制造限制要素的体会。 以下文章来源于华谷研究院 ，作者刘修才 华谷研究院 . 打造高水平思想库，开展生物经济领域的前沿技术问题、政策问题研究、为政商资研学提供交流平台，促进技术、资本、人才、服务和市场等要素配置， 推动中国生物经济的跨越式发展。 以下分享来源于 凯赛生物刘修才博 士 在 生物经济50人论坛上的演讲分享。 【SynBioCon】 转载，与行业共勉！ 首先，我认为任何一个高科技的成功，都要重视科研投入，但科研要是不依赖企业都是没戏。 我个人从来不赞成必须产学研结合的说法，这是个不 成立的话题。如果企业没有研究能力，就不是高科技企业、也不可能既强又大；如果高科技企业不掌握核心技术，也不可能有竞争力。 没有企业创新导致差异化，大家就回到传统的制造业上面来了——互相卷。我不是说高校和研究机构不发挥作用。生物制造这里面有很多基础和前 沿技术应当来自于高校和研究机构，因为多数企业不愿意投钱或没有能力做基础研究。 但是如果高校和研究机构都去搞应用性技术开发，这肯定不着调。在基础研究和应用性技术开发区间有一个灰色区域，也就是这个灰色区域给很多 人钻了空子， ...

Project Overview - The project is named "Annual Production of 12,000 Tons of Bio-based Tryptophan Renovation and Expansion Project" [2] - The construction unit is Qinhuangdao Huaheng Biological Engineering Co., Ltd. [2] - The project is located in the Shanhaiguan District of Qinhuangdao City, Hebei Province [2] Project Details - The total construction area is 37,075 square meters [2] - The project will utilize bio-based malic acid and its derivatives, including fermentation systems and extraction equipment [2] - The project aims to maintain the existing production capacity of malic acid and its derivatives while achieving a flexible production of 12,000 tons/year of tryptophan [2] Existing Infrastructure - Qinhuangdao Huaheng Biological Engineering Co., Ltd. currently operates three fermentation workshops, one refining workshop, one extraction workshop, and additional facilities including a wastewater treatment station and warehouses [2]

【SynBioCon】 获悉，4月29日晚间， 凯赛生物 发布2025年第一季度报告，报告期内实现 营业 收入7.76亿元，同比增长13.3%；归母净利润1.37亿元，同比上升30.1% ；扣非归母净利润1.35 亿元，同比上升31.4%；研发投入6055.06万元，同比增长35.21%。继续延续了2024年的好成 绩。 业绩增长主要系本期公司系列长链二元酸持续放量，销售收入以及销售毛利增长所致。 | | | 单位: 元 | 市种:人民币 | | --- | --- | --- | --- | | | | | 本报告期比上 | | 项目 | 本报告期 | 上年同期 | 年同期增减变 | | | | | 动幅度(%) | | 营业收入 | 775,769, 935. 75 | 684, 521, 536. 95 | 13. 33 | | 归属于上市公司股东的净利润 | 136, 950, 113. 57 | 105, 258, 699. 94 | 30. 11 | | 归属于上市公司股东的扣除非 | 135, 362, 505. 06 | 102, 994, 926. 66 | 31. 43 | | 经常性损益 ...

在全球范围汽车制造上为践行可持续发展和环保理念，应用生物基的汽车数量不断攀升。 生物基工程塑料 、 生物基复合材料、生物基聚氨酯和树脂等材 料 在探索 整车内外饰如 座 椅、仪表盘、织 物、皮革、涂料、灯具、格栅、轮胎等 部件 的应用替代上热度不减。 整车企业的可持续战略与材料需求是什么 ？ 生物基材料在汽车应用的现状 、 哪些生物基材料解决方案将成为"新兴黑马" ? 2025（第十届）生物基大会暨展览 （简称：Bio-based 2025）" 将同期举办" 可持续应用论坛—— 汽车专场 " （ 5月26日，上海 ）。本专场将出 席 广汽研究院、延峰汽车、蔚来汽车、第一汽车、固特异等 整车及零部件企业 ， 玛斯新材、三菱化学、阿朗新科、郑州中远集团等 生物基新材料开发和 解决方案企业 ，共同分享以上行业关注问题。 14:50 主题信元 15:15 周楠婷 蔚来汽车 主任工程师、博士 15:15 新型生物基聚碳酸酯DURABIO的特征与应用 15:40 闫家林 =菱化学 三菱化学(中国)管理有限公司 DURABIO中国区主要技术负责人 15:40 ■ 茶歇交流 16:10 16:10 "碳"寻绿色发展路径,打造 ...